World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

Swiss Re Independently Validates 25:1 Return on Investment for Cancer Rehabilitation. Osara Health Delivered 91% of the Program Data.

Cision PR Newswire by Cision PR Newswire
April 7, 2026
in Press Releases
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Osara Health discloses its role as the primary cancer support provider in Swiss Re’s independent Rehabilitation Watch 2025 report, which confirmed a 25:1 return on investment and the highest return-to-work rate of any condition at 71%.

NEW YORK, April 7, 2026 /PRNewswire/ — Swiss Re’s Rehabilitation Watch 2025 has confirmed a 25:1 return on investment for cancer-specific rehabilitation support within the Australian life insurance sector. Of the cancer support program data analyzed, 91% came from Osara Health.


Osara Health (PRNewsfoto/Osara Health)

The independent report, the first to aggregate rehabilitation outcomes across the Australian life insurance market, analyzed 2,348 customers from 12 providers across all seven of Australia’s largest life insurers. It found that for every $1 invested in cancer rehabilitation, insurers saw $25.84 in reduced reserves. Cancer customers also achieved the highest return-to-work rate of any condition in the study at 71%.

All provider data was de-identified and aggregated prior to analysis. Osara Health did not commission or author the report. Swiss Re analyzed and published the findings independently. Osara Health’s participation as the primary cancer support provider is disclosed here for the first time.

“For years, the insurance sector has known there’s a gap between clinical treatment and full recovery,” said Dr Raghav Murali Ganesh, CEO of Osara Health and Radiation Oncologist. “This study puts a number on what filling that gap is worth: 25:1. Independent validation from Swiss Re, built on data from our program, confirms that structured cancer support isn’t a nice-to-have. It’s one of the highest-returning rehabilitation investments an insurer can make.”

The report also reinforced the value of earlier intervention, with claims referred within six weeks achieving a 79% return-to-work rate. The median referral time for cancer customers was 42 weeks, pointing to a significant opportunity for insurers to improve outcomes by engaging structured support sooner.

About Osara Health
Osara Health is a leading provider of evidence-based cancer support programs. By combining digital tools with specialized human coaching, Osara Health empowers people impacted by cancer to take control of their health outcomes. The organization partners with insurers and employers to improve the experience of cancer care, delivering clinically validated interventions that support wellbeing and return-to-work outcomes.

Media Contact
Chloe Pickering
Osara Health
marketing@osarahealth.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/swiss-re-independently-validates-251-return-on-investment-for-cancer-rehabilitation-osara-health-delivered-91-of-the-program-data-302734897.html

SOURCE Osara Health

Cision PR Newswire

Cision PR Newswire

Related Posts

Beijing Launches ‘GO BEIJING’ for One-Stop Services for Inbound Visitors

April 30, 2026

Elkem: First quarter 2026 – Strategic transformation and strengthening financial resilience

April 30, 2026

Hexagon releases new targets at its Capital Markets Day 2026

April 30, 2026

PB Master Program Debuts: Xtep’s New Global Support Platform for Marathon Runners

April 30, 2026

Lancashire Holdings Limited – Results of the Annual General Meeting (AGM) Statement

April 30, 2026

Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases

April 30, 2026

Popular News

  • PB Master Program Debuts: Xtep’s New Global Support Platform for Marathon Runners

    0 shares
    Share 0 Tweet 0
  • Hexagon releases new targets at its Capital Markets Day 2026

    0 shares
    Share 0 Tweet 0
  • Elkem: First quarter 2026 – Strategic transformation and strengthening financial resilience

    0 shares
    Share 0 Tweet 0
  • Beijing Launches ‘GO BEIJING’ for One-Stop Services for Inbound Visitors

    0 shares
    Share 0 Tweet 0
  • Aktia Bank Plc’s Interim Report January-March 2026: Continued positive development in international sales, but the result was weighed down by changes in market values in the life insurance business

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler